JGC

J. Goldman & Co Portfolio holdings

AUM $3.18B
1-Year Return 9.17%
This Quarter Return
+5.81%
1 Year Return
+9.17%
3 Year Return
+56.93%
5 Year Return
+78.85%
10 Year Return
+152.96%
AUM
$1.75B
AUM Growth
+$29.1M
Cap. Flow
-$57.8M
Cap. Flow %
-3.3%
Top 10 Hldgs %
26.35%
Holding
422
New
98
Increased
67
Reduced
59
Closed
100

Sector Composition

1 Technology 23.34%
2 Consumer Discretionary 19.81%
3 Industrials 16.26%
4 Healthcare 9.69%
5 Communication Services 5.63%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
WSM icon
326
Williams-Sonoma
WSM
$24.7B
-3,676
Closed -$224K
XBI icon
327
SPDR S&P Biotech ETF
XBI
$5.39B
0
XLY icon
328
Consumer Discretionary Select Sector SPDR Fund
XLY
$23.6B
-92,623
Closed -$13.9M
ZNTL icon
329
Zentalis Pharmaceuticals
ZNTL
$126M
0
WIRE
330
DELISTED
Encore Wire Corp
WIRE
-61,570
Closed -$11.4M
RMGC
331
DELISTED
RMG Acquisition Corp. III Class A Ordinary Shares
RMGC
0
KRTX
332
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
0
XPDBU
333
DELISTED
Power & Digital Infrastructure Acquisition II Corp. Unit
XPDBU
-450,000
Closed -$4.64M
RAIN
334
DELISTED
Rain Oncology Inc. Common Stock
RAIN
0
CCVI
335
DELISTED
Churchill Capital Corp VI
CCVI
-294,449
Closed -$2.98M
NATI
336
DELISTED
National Instruments Corp
NATI
-41,004
Closed -$2.15M
WWE
337
DELISTED
World Wrestling Entertainment
WWE
0
HIMS icon
338
Hims & Hers Health
HIMS
$10.9B
-62,084
Closed -$616K
HON icon
339
Honeywell
HON
$136B
-48,878
Closed -$9.34M
HPQ icon
340
HP
HPQ
$27.4B
-295,929
Closed -$8.69M
HTGC icon
341
Hercules Capital
HTGC
$3.49B
0
HYG icon
342
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.8B
0
HYFM icon
343
Hydrofarm Holdings
HYFM
$15.4M
0
IBB icon
344
iShares Biotechnology ETF
IBB
$5.8B
0
IGV icon
345
iShares Expanded Tech-Software Sector ETF
IGV
$9.85B
-218,750
Closed -$13.3M
IMTXW
346
DELISTED
Immatics N.V. Warrants
IMTXW
0
INCY icon
347
Incyte
INCY
$16.9B
0
ABG icon
348
Asbury Automotive
ABG
$5.06B
-34,909
Closed -$7.33M
ABNB icon
349
Airbnb
ABNB
$75.8B
0
ACAD icon
350
Acadia Pharmaceuticals
ACAD
$4.26B
0